Glenmark Pharmaceuticals net profit declines 42.71% in the March 2013 quarter
Capital MarketNet profit of Glenmark Pharmaceuticals declined 42.71% to Rs 84.92 crore in the quarter ended March 2013 as against Rs 148.23 crore during the previous quarter ended March 2012. Sales rose 7.54% to Rs 484.14 crore in the quarter ended March 2013 as against Rs 450.20 crore during the previous quarter ended March 2012.
For the Audited full year,net profit rose 45.54% to Rs 386.11 crore in the year ended March 2013 as against Rs 265.30 crore during the previous year ended March 2012. Sales rose 25.11% to Rs 1935.29 crore in the year ended March 2013 as against Rs 1546.82 crore during the previous year ended March 2012.
ParticularsQuarter EndedYear EndedMar. 2013Mar. 2012% Var.Mar. 2013Mar. 2012% Var.Sales484.14450.20
8 1935.291546.82
25 OPM %12.0132.31
-63 17.1820.10
-15 PBDT78.40146.69
-47 405.00305.21
33 PBT71.97141.14
-49 379.96284.10
34 NP84.92148.23
-43 386.11265.30
46 Powered by Capital Market - Live News
